Literature DB >> 6621871

Crossed aphasia in dextrals: a case report with special reference to site of lesion.

M Habib, Y Joanette, A Ali-Cherif, M Poncet.   

Abstract

A strictly right-handed man showed aphasia and left hemiplegia following a deep infarct of the right hemisphere. Aphasic semeiology was characterized by an oral and written jargon while comprehension was almost intact. Several hypotheses previously put forward fail to account for the patient's aphasia. Emphasizing the frequency of deep structures involvement in the published cass of crossed dextral aphasias, it is suggested that site of lesion may have a certain part to play in the occurrence of such aphasias.

Entities:  

Mesh:

Year:  1983        PMID: 6621871     DOI: 10.1016/0028-3932(83)90029-5

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  5 in total

Review 1.  Aphasia due to lesions confined to the right hemisphere in right handed patients: a review of the literature including the Italian cases.

Authors:  L Faglia; M R Rottoli; L A Vignolo
Journal:  Ital J Neurol Sci       Date:  1990-04

2.  Crossed aphasia following cerebral infarction in a right-handed patient with atypical cerebral language dominance.

Authors:  Xiaoping Tan; Yang Guo; Saihong Dun; Hongzan Sun
Journal:  J Neurol       Date:  2018-05-18       Impact factor: 4.849

3.  Acute aphasia after right hemisphere stroke.

Authors:  Géraldine Maillard Dewarrat; Jean-Marie Annoni; Eleonora Fornari; Antonio Carota; Julien Bogousslavsky; Philippe Maeder
Journal:  J Neurol       Date:  2009-04-12       Impact factor: 4.849

4.  Crossed aphasia: a PET follow up study of two cases.

Authors:  S F Cappa; D Perani; S Bressi; E Paulesu; M Franceschi; F Fazio
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154

5.  Neural substrate responsible for crossed aphasia.

Authors:  Woo Jin Kim; Eun Joo Yang; Nam-Jong Paik
Journal:  J Korean Med Sci       Date:  2013-09-25       Impact factor: 2.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.